Celldex Therapeutics Inc.

(CLDX) Trade

By |

Profile

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.

Contact Information

Website: www.celldex.com
Email: ir@celldextherapeutics.com
Main Phone: +1 908 200-7500
Address: 53 Frontage Road
Address 2: Suite 220
State: NJ
City / Town: Hampton
Country: USA
Postal Code: 08827

Issuer Information

Exchange: NSC
CEO: Anthony S. Marucci
Employees: 130
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

View More

Profile

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140, and CDX-3379.

Contact Information

Website: www.celldex.com
Email: ir@celldextherapeutics.com
Main Phone: +1 908 200-7500
Address: 53 Frontage Road
Address 2: Suite 220
State: NJ
City / Town: Hampton
Country: USA
Postal Code: 08827

Issuer Information

Exchange: NSC
CEO: Anthony S. Marucci
Employees: 130
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)

Equities News

View More
$ 12.41 $ 0.26 (2.14%)
Last Price 12.41 Change $ 0.26 Change % 2.14 Tick N/A
Bid 11.91 Bid Size 300.00 Ask 12.63 Ask Size 300.00
Open 12.09 High 12.72 Low 11.90 Prev Close 12.15
Last Trade Volume 556,286 52 Wk Hi 13.91 52 Wk Low 1.50
Market Cap 481.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,827,918.00 EPS (TTM) -2.91 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 18
Number of Buys 0 7
Number of Sells 3 11
Net Activity -9005 34783
Last 10 Buys Shares
Tibor Keler 1,000
Larry Ellberger 1,000
Larry Ellberger 1,000
Larry Ellberger 1,000
Larry Ellberger 1,000
Larry Ellberger 1,000
Larry Ellberger 1,000
Anthony S. Marucci 1,000
Tibor Keler 1,000
Avery W. Catlin 1,000
Last 10 Sell Shares
Avery W. Catlin 1,000
Avery W. Catlin 1,000
Avery W. Catlin 1,000
Larry Ellberger 1,000
Harry H. Penner 1,000
Karen L. Shoos 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 1 1 1 1
Mean Target Price Estimate 2.05 2.05 2.05 2.05
Standard Deviation 1 1 1 1
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 3 3
Moderate Buy 0 0 0 0
Hold 3 3 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.5 2.5 1.5 1.8